Tissue engineered nigrostriatal pathway for treatment of Parkinson's disease.

Tissue engineered nigrostriatal pathway for treatment of Parkinson's disease.
复制标题

DOI:
10.1002/term.2698
复制
发表时间:
2018-07
影响因子:
3.3
通讯作者:
Cullen DK
Cullen DK
中科院分区:
工程技术3区
文献类型:
--
作者:
Struzyna LA;Browne KD;Brodnik ZD;Burrell JC;Harris JP;Chen HI;Wolf JA;Panzer KV;Lim J;Duda JE;España RA;Cullen DK

文献摘要

参考文献

相似文献

The classic motor deficits of Parkinson’s disease are caused by degeneration of dopaminergic neurons in the substantia nigra pars compacta, resulting in the loss of their long-distance axonal projections that modulate the striatum. Current treatments only minimize the symptoms of this disconnection as there is no approach capable of replacing the nigrostriatal pathway. We are applying micro-tissue engineering techniques to create living, implantable constructs that mimic the architecture and function of the nigrostriatal pathway. These constructs consist of dopaminergic neurons with long axonal tracts encased within hydrogel micro-columns. Micro-columns were seeded with dopaminergic neuronal aggregates, while lumen extracellular matrix (ECM), growth factors, and end targets were varied to optimize cytoarchitecture. We found a 10-fold increase in axonal outgrowth from aggregates versus dissociated neurons, resulting in remarkable axonal lengths of over 6 mm by 14 days and 9 mm by 28 days in vitro. Axonal extension was also dependent upon lumen ECM, but did not depend on growth factor enrichment or neuronal end target presence. Evoked dopamine release was measured via fast scan cyclic voltammetry and synapse formation with striatal neurons was observed in vitro. Constructs were microinjected to span the nigrostriatal pathway in rats, revealing survival of implanted neurons while maintaining their axonal projections within the micro-column. Lastly, these constructs were generated with dopaminergic neurons differentiated from human embryonic stem cells. This strategy may improve Parkinson’s disease treatment by simultaneously replacing lost dopaminergic neurons in the substantia nigra and reconstructing their long-projecting axonal tracts to the striatum.
DOI: 10.1038/nature10648
发表时间: 2011-11-06
期刊: NATURE
影响因子: 64.8
作者:
Kriks, Sonja;Shim, Jae-Won;Piao, Jinghua;Ganat, Yosif M.;Wakeman, Dustin R.;Xie, Zhong;Carrillo-Reid, Luis;Auyeung, Gordon;Antonacci, Chris;Buch, Amanda;Yang, Lichuan;Beal, M. Flint;Surmeier, D. James;Kordower, Jeffrey H.;Tabar, Viviane;Studer, Lorenz
通讯作者: Studer, Lorenz
DOI: 10.1634/stemcells.2006-0119
发表时间: 2006-11-01
期刊: STEM CELLS
影响因子: 5.2
作者:
Lin, Ling;Isacson, Ole
通讯作者: Isacson, Ole
DOI: 10.1039/b307024g
发表时间: 2003-01-01
期刊: ANALYST
影响因子: 4.2
作者:
Heien, MLAV;Phillips, PEM;Wightman, RM
通讯作者: Wightman, RM
DOI: 10.1089/ten.tea.2011.0534
发表时间: 2012-11-01
影响因子: 4.1
作者:
Cullen, D. Kacy;Tang-Schomer, Min D.;Smith, Douglas H.
通讯作者: Smith, Douglas H.
DOI: 10.1016/j.stem.2014.09.017
发表时间: 2014-11-06
期刊: CELL STEM CELL
影响因子: 23.9
作者:
Grealish, Shane;Diguet, Elsa;Kirkeby, Agnete;Mattsson, Bengt;Heuer, Andreas;Bramoulle, Yann;Van Camp, Nadja;Perrier, Anselme L.;Hantraye, Philippe;Bjorklund, Anders;Parmar, Malin
通讯作者: Parmar, Malin